NCT03045705 is a NA clinical trial of Routine pain management in Labor Pain, sponsored by Rambam Health Care Campus.

Who is sponsoring NCT03045705?

NCT03045705 is sponsored by Rambam Health Care Campus.

What drugs are being tested in NCT03045705?

Interventions in NCT03045705: Routine pain management, No inquiry regarding analgesia.

What condition does NCT03045705 study?

NCT03045705 studies Labor Pain.

Is NCT03045705 still recruiting?

NCT03045705 is currently withdrawn. Last updated 16 September 2020.

Last reviewed 2020-09-16 · How we verify

NCT03045705

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of the Effect the Medical Team in the Delivery Room Has on Pain Management During Labor.

Withdrawn NA Last updated 16 September 2020

What this trial tests

NA trial testing Routine pain management in Labor Pain. Withdrawn.

Timeline

1 March 2019

Primary endpoint
31 July 2020

1 September 2020

Quick facts

Lead sponsor	Rambam Health Care Campus
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Start date	1 March 2019
Primary completion	31 July 2020
Estimated completion	1 September 2020
Sites	1 location across Israel

Drugs / interventions tested

Routine pain management
No inquiry regarding analgesia

Conditions studied

Labor Pain — all drugs for Labor Pain →

Sponsor

Rambam Health Care Campus — full company profile →

Who can join

Adults 18 to 44, female only, with Labor Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In the current study the investigators wish to evaluate the effect the doctors and midwives in the delivery room have on the timing and modality of analgesia chosen by the participants. The participants will be randomly divided into 2 groups. Both groups will be advised of the different modalities of analgesia available during labor. One group will be managed in the delivery room the same as if not part of the study, meaning the doctors and midwives will treat the participants the way they usually do regarding analgesia. The second group of participants will not be asked by the doctors and midwives about analgesia at all but will be able to receive analgesia by a modality of choice at the timing of choice.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Labor Pain

Currently open trials in the same condition.

NCT07440069 — Analgesic Efficacy and Obstetric Effects of Tramadol, Paracetamol and Placebo in Active Labor · Phase 4 · recruiting
NCT07411352 — Left Lateral Position vs Supine Position to Reduce Active Labor Duration · NA · recruiting
NCT07401147 — Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Management During Labor. · NA · recruiting
NCT07395934 — Comparing PIEB and CEI for Labor Pain Relief · NA · recruiting
NCT06819579 — Exploring the Optimal Concentration of Lidocaine Test Dose for Labor Analgesia · NA · active not recruiting

Other Rambam Health Care Campus trials

Trials by the same sponsor.

NCT07384013 — Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs · NA · recruiting
NCT06688253 — Intravenous Human IgG1 Fc Fragment (Efgartigimod) in Myasthenic Crisis · Phase 4 · not yet recruiting
NCT06235749 — Administration Of Calcium Gluconate for The Reduction of Blood Loss During Elective Cesarean Delivery · NA · recruiting
NCT06622902 — Influence of Flow Rate Change on CO2 Levels During High Flow Nasal Ventilation (HFNV) in Preterm Infants. · NA · recruiting
NCT05922111 — Cervical Ripening Balloon for 12 Hours vs. 1 Hour. · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03045705 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rambam Health Care Campus
Last refreshed: 16 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03045705.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing